Due to the extremely high PTH level with hypocalcemia, and in order to assess the clinical and biochemical response to calcium replacement, we admitted the proband (Sibling 1) and started her on a continuous intravenous calcium infusion titrated according to serum calcium levels monitored every 4 hours (Figure 2). The gene discussed is PTH; the disease is Hypocalcemia.